Maryland Heights, MO, January 07, 2017 --(PR.com
)-- The global angioplasty balloons market is growing at the rate of 4.5% CAGR and is estimated to reach USD 2.1 Billion by 2020 due to high prevalence of coronary artery diseases and geriatric population, according to a new report published by iHealthcareAnalyst, Inc.
Browse Angioplasty Balloons Market – Balloon Type (Normal, Cutting, Drug Coated and Scoring Balloons), Materials Used (Non-Compliant and Semi-Compliant Balloons 2016-2020 at https://www.ihealthcareanalyst.com/report/angioplasty-balloons-market/
Angioplasty balloons widens the narrow or obstructed blood vessel using a balloon catheter to treat atherosclerosis (blood vessel obstructions). Balloon angioplasty is a minimally invasive procedure that widens the obstructed blood vessels. PTA or PTCA is a minimally invasive catheter based technology that enables treatment of coronary and peripheral artery disease. In this technique balloons are utilized for the clearance of artery which have been blocked due to deposition of fatty material. These balloon catheters compress the plaques within a blocked coronary or peripheral artery.
The angioplasty balloons market report estimates the market size (Revenue USD million – 2013 to 2020) for key market segments based on balloon type (normal, cutting, drug coated and scoring balloons), materials used (non-compliant and semi-compliant balloons), and forecasts growth trends (CAGR% – 2016 to 2020).
The global angioplasty balloons market segmentation is based on geography (regional and country based). The global angioplasty balloons market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments. The global angioplasty balloons market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.
Major players profiled in this report include Abbott Laboratories, Inc., BIOTRONIK SE & CO. KG, Boston Scientific Corporation, Cook Medical, Cordis Corporation, C. R. Bard, Inc., ENDOCOR GmbH, Medtronic plc, Opto Circuits (India) Limited, NATEC Medical, and Spectranetics Corporation.
To request Table of Contents and Sample Pages of this report visit:
iHealthcareAnalyst, Inc. is a global health care market research and consulting company providing market analysis, and competitive intelligence services to global clients. The Company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.
iHealthcareAnalyst, Inc. provides industry participants and stakeholders with strategically analyzed, unbiased view of market dynamics and business opportunities within its coverage areas.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043